Investec Bank plc has filed a public dealing disclosure under Rule 8.5 of the UK Takeover Code relating to Advanced Medical Solutions Group Plc (AIM: AMS).
The disclosure, dated June 17, 2026, covers transactions undertaken on June 16, 2026, by Investec acting as an exempt principal trader with recognised intermediary status.
Investec holds a significant role in this matter, serving as both advisor and joint broker to Advanced Medical Solutions Group plc in connection with the relevant offer.
The filing falls under Form 8.5 (EPT/RI), which requires exempt principal traders dealing in a client-serving capacity to publicly disclose their activities during an offer period.
According to the disclosure, Investec purchased 33,355 ordinary shares in Advanced Medical Solutions Group at a price of 214 pence per unit.
In the same dealing period, Investec also sold 33,355 ordinary shares at an equivalent price of 214 pence per unit, reflecting a matched client-serving transaction.
No cash-settled derivative transactions were reported as part of this disclosure, with those sections of the form marked not applicable.
Similarly, no stock-settled derivative transactions, including options of any kind, were recorded in connection with the June 16 dealings.
Investec confirmed that no indemnity arrangements, options, or informal agreements exist that could serve as an inducement to deal or refrain from dealing in the relevant securities.
The bank also stated that no agreements or understandings relating to voting rights or future acquisitions tied to derivatives are in place with any other party.
The disclosure was prepared by contact Abhishek Gawde and submitted in accordance with the Panel on Takeovers and Mergers’ regulatory requirements for market transparency during offer periods.
Public disclosures under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure visibility across market participants.
